17,881 resources
By Version
By Realm
Start Prev Rows 16200 - 16400 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| hl7.fhir.cz.lab | R4 | cz-lab-container-types-VS | Laboratory Container Types (CZ) | active | 2022-08 | cz | sct | ||
| hl7.fhir.pl.ssidl | R5 | ssidl-refRangeMeaning-VS | Typy wartości referencyjnych | draft | 2025-08 | pl | tho | ||
| hl7.fhir.cl.minsal.nid | R4 | VSTituloProfesional | Título Profesional | active | 2023-01 | cl | internal | ||
| hl7.fhir.ee.mpi | R5 | occupation-type | Occupation Type | draft | 2023-12 | ee | internal | ||
| ee.fhir.terminology | R5 | tootamise-liik | Töötamise liik | active | 2025-06 | ee | internal | ||
| ee.fhir.terminology | R5 | toovoime-liik | Töövõime liik | active | 2025-06 | ee | internal | ||
| hl7.fhir.ee.mpi | R5 | incapacity-for-work-category | Category of Incapacity For Work | draft | 2023-12 | ee | internal | ||
| hl7.fhir.dk.core | R4 | dk-core-UCUM-BasicUnits | DK Core UCUM Basic Units | active | 2025-02 | dk | ucum | ||
| hl7.fhir.cz.img-order | R4 | cz-observationUnitsHeight-vs | ObservationsUnitHeight | active | 2024-01 | cz | ucum | ||
| nictiz.fhir.nl.r4.zib2020 | R4 | zib-BodyWeight-units | zib BodyWeight units | draft | nl | ucum | |||
| hl7.fhir.cz.img-order | R4 | cz-observationUnitsWeight-vs | ObservationsUnitWeight | trial-use | 2 | 2024-01 | cz | ucum | |
| fhir.virtually.healthcare | R4 | UKCorrelationIdentifier | UK Common Resource Identifiers | draft | 2025-08 | us | internal | ||
| fhir.virtually.healthcare | R4 | UKNationalIdentifiers | UK National Insurance Identifiers | draft | 2025-08 | us | internal | ||
| fhir.virtually.healthcare | R4 | ProfessionalLicense | UK Professional License | draft | 2025-08 | us | internal | ||
| uk.nhsdigital.r4.test | R4 | effdbf4d-a7e3-47dd-9f94-ebe84ed970df | NHSDigital Action Code | draft | 2022-03 | sct | |||
| fhir.virtually.healthcare | R4 | StaffNumber | UK StaffNumber | draft | 2025-08 | us | internal | ||
| hl7.fhir.us.davinci-pct | R4 | USClaimDRGCodes | US Claim DRG Codes | trial-use | fm | 2025-08 | us | cms | |
| fhir.cdc.opioid-cds-r4 | R4 | condition-us-core-health-concern-category | US Core Health Concern Condition Category | active | 2023-05 | us | |||
| nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.33.1--20200901000000 | UiterlijkeVerzorgingCodelijst | active | nl | sct | |||
| nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.33.1--20171231000000 | UiterlijkeVerzorgingCodelijst | active | nl | sct | |||
| nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.7--20200901000000 | UitvoerenTransferCodelijst | active | nl | sct | |||
| nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.7--20171231000000 | UitvoerenTransferCodelijst | active | nl | sct | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.4469 | Cabotegravir Injectable Products | active | 2024-05 | us | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.4470 | Emtricitabine oral for HIV PrEP | active | 2024-05 | us | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.4474 | HIV Laboratory Based Tests | active | 2024-05 | us | loinc | ||
| hl7.fhir.cl.recetachile | R4 | VSUnidadAsistencial | Unidad Asistencial | active | 2022-01 | cl | internal | ||
| hl7.terminology | R5 | ucum-units | UCUM Codes | active | fhir | 2023-11 | uv | ucum | |
| ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-amount-quantity-unit-code | Amount Quantity Unit Codes | draft | 2025-01 | ch | ucum sct | ||
| ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-time-quantity-unit-code | Time Quantity Unit Codes | draft | 2025-01 | ch | ucum | ||
| hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-image-guided-radiotherapy-energy-unit-vs | Image Guided Radiotherapy Energy Unit Value Set | draft | cgp | 2025-02 | us | ucum | |
| hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-energy-unit-vs | Radiotherapy Energy Unit Value Set | draft | cgp | 2025-02 | us | ucum | |
| ch.fhir.ig.ch-term | R4 | UnitCode | UnitCode | active | 2025-05 | ch | ucum sct | ||
| hl7.terminology | R5 | v3-GTSAbbreviationHolidaysUSNational | GTSAbbreviationHolidaysUSNational | active | 2014-03 | uv | tho | ||
| hl7.fhir.eu.imaging-manifest-r5 | R5 | im-dose-length-units | Dose Length Units | draft | 2025-07 | eu | ucum | ||
| hl7.fhir.eu.imaging-r5 | R5 | im-dose-length-units | Dose Length Units | draft | 2025-08 | eu | ucum | ||
| hl7.fhir.cz.img | R4 | im-dose-length-units | Dose Length Units | draft | 2025-08 | cz | ucum | ||
| hl7.fhir.eu.imaging-manifest-r5 | R5 | im-effective-dose-units | Effective Dose Units | draft | 2025-07 | eu | ucum | ||
| hl7.fhir.eu.imaging-r5 | R5 | im-effective-dose-units | Effective Dose Units | draft | 2025-08 | eu | ucum | ||
| hl7.fhir.cz.img | R4 | im-effective-dose-units | Effective Dose Units | draft | 2025-08 | cz | ucum | ||
| hl7.fhir.eu.imaging-manifest-r5 | R5 | im-gray-square-units | Gray Square Units | draft | 2025-07 | eu | ucum | ||
| hl7.fhir.eu.imaging-r5 | R5 | im-gray-square-units | Gray Square Units | draft | 2025-08 | eu | ucum | ||
| hl7.fhir.cz.img | R4 | im-gray-square-units | Gray Square Units | draft | 2025-08 | cz | ucum | ||
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-non-percentage-units | Non-Percentage Units | trial-use | 2 | brr | 2025-07 | us | fhir |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-percentage-units | Percentage Units | trial-use | 2 | brr | 2025-07 | us | ucum |
| hl7.fhir.uv.emedicinal-product-info | R5 | unitofPresentation | Units of Presentation | active | 2025-07 | uv | fhir | ||
| hl7.eu.fhir.unicom | R5 | unit-of-measurement-vs | EMA SPOR Unit of Measurement | draft | 2025-06 | eu | |||
| hl7.eu.fhir.unicom | R5 | unit-of-presentation-vs | EMA SPOR Unit of Presentation | draft | 2025-06 | eu | |||
| hl7.eu.fhir.pcsp | R4 | vs-unknownOther-eu-pcsp | Unknown|Other | draft | 2025-08 | eu | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.41 | Tobacco Use | active | 2024-06 | us | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.90 | Gestational Diabetes | active | 2024-06 | us | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1921 | Beta Blocker Therapy Ingredient | active | 2024-02 | us | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1493 | Beta Blocker Therapy Ingredient | active | 2017-05 | us | vsac | ||
| hl7.terminology | R5 | v3-UreteralRoute | UreteralRoute | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-UrethralRoute | UrethralRoute | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-UrinaryBladderRoute | UrinaryBladderRoute | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-UrinaryTractRoute | UrinaryTractRoute | active | 2014-03 | uv | tho | ||
| fhir.cdc.opioid-cds-r4 | R4 | cocaine-urine-drug-screening-tests | Cocaine urine drug screening tests | active | 2023-05 | us | |||
| fhir.cdc.opioid-cds-r4 | R4 | fentanyl-type-urine-drug-screening-tests | Fentanyl-type urine drug screening tests | active | 2023-05 | us | |||
| fhir.cdc.opioid-cds-r4 | R4 | opiate-specific-urine-drug-screening-tests | Opiate specific urine drug screening tests | active | 2023-05 | us | |||
| fhir.cdc.opioid-cds-r4 | R4 | phencyclidine-urine-drug-screening-tests | Phencyclidine urine drug screening tests | active | 2023-05 | us | |||
| fhir.cdc.opioid-cds-r4 | R4 | synthetic-opioid-urine-drug-screening-tests | Synthetic opioid urine drug screening tests | active | 2023-05 | us | |||
| fhir.cdc.opioid-cds-r4 | R4 | all-urine-drug-screening-tests | All urine drug screening tests | active | 2023-11 | us | internal | ||
| fhir.cdc.opioid-cds-r4 | R4 | methadone-urine-drug-screening-tests | Methadone urine drug screening tests | active | 2023-05 | us | loinc | ||
| fhir.cdc.opioid-cds-r4 | R4 | amphetamine-urine-drug-screening-tests | Amphetamine-class drugs and metabolite urine tests | active | 2023-05 | us | loinc | ||
| nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.14.2--20171231000000 | UrineKatheterTypeCodelijst | active | nl | fhir sct | |||
| hl7.fhir.us.vdor | R4 | vdor-use-of-prescription-morphine-vs | VDOR Use of Prescription Morphine | informative | pher | 2025-06 | us | fhir | |
| signal.core.r4 | R4 | contact-point-use | ContactPointUse | draft | 0 | fhir | 2019-10 | us | fhir |
| nictiz.fhir.nl.r4.zib2020 | R4 | ContactInformation-EmailAddressesUse | ContactPointUse ValueSet for zib ContactInformation EmailAddress | active | nl | fhir | |||
| nictiz.fhir.nl.r4.zib2020 | R4 | ContactInformation-TelephoneNumbersUse | ContactPointUse ValueSet for zib ContactInformation TelephoneNumbers | active | nl | fhir | |||
| nhsd.assets.stu3 | R3 | EMS-ContactPointUse-1 | ContactPointUse | draft | 0 | fhir | 2017-04 | fhir | |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.1444.3.227 | Neoplasm of Brain | active | 2024-07 | us | icd | ||
| hl7.fhir.us.carin-bb | R4 | C4BBAdjudicationCategoryDiscriminator | C4BB Adjudication Category Discriminator Value Set | trial-use | fm | 2025-02 | us | fhir | |
| hl7.fhir.us.davinci-pdex | R4 | PDexAdjudicationCategoryDiscriminator | PDex Adjudication Category Discriminator | informative | fm | 2025-06 | us | fhir | |
| hl7.fhir.us.carin-bb | R4 | C4BBSupportingInfoType | C4BB SupportingInfo Type Value Set | trial-use | fm | 2025-02 | us | fhir | |
| hl7.fhir.us.davinci-pdex | R4 | PDexSupportingInfoType | PDex SupportingInfo Type | informative | fm | 2025-06 | us | fhir | |
| hl7.fhir.us.carin-bb | R4 | C4BBTotalCategoryDiscriminator | C4BB Total Category Discriminator Value Set | trial-use | fm | 2025-02 | us | fhir | |
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.44 | Mental and Functional Status Response | active | 2024-06 | us | sct | ||
| hl7.terminology | R5 | v3-ActRelationshipSymptomaticRelief | ActRelationshipSymptomaticRelief | active | 2014-03 | uv | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.1444.5.244 | Anthracycline Injectable | active | 2024-10 | us | vsac | ||
| hl7.terminology | R5 | v3-ActRelationshipAssignsName | ActRelationshipAssignsName | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ActRelationshipInstantiatesMaster | ActRelationshipInstantiatesMaster | active | 2014-03 | uv | tho | ||
| hl7.fhir.us.core | R4 | us-core-clinical-result-observation-category | US Core Clinical Result Observation Category | trial-use | 3 | cgp | 2023-04 | us | tho |
| hl7.terminology | R5 | contributor-summary-type | Contributor Summary Type | trial-use | 1 | cds | 2025-01 | uv | tho |
| hl7.terminology | R5 | contributor-role | Contributor Role | trial-use | 1 | cds | 2025-01 | uv | tho |
| hl7.terminology | R5 | contributor-summary-style | Contributor Summary Style | trial-use | 1 | cds | 2025-01 | uv | tho |
| hl7.terminology | R5 | contributor-summary-source | Contributor Summary Source | trial-use | 1 | cds | 2025-01 | uv | tho |
| hl7.terminology | R5 | v3-ActRelationshipActProvenance | ActRelationshipActProvenance | active | 2014-08 | uv | tho | ||
| hl7.terminology | R5 | v3-ActRelationshipDocumentProvenance | ActRelationshipDocumentProvenance | active | 2014-08 | uv | tho | ||
| hl7.terminology | R5 | v3-xDocumentProcedureMood | x_DocumentProcedureMood | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-xDocumentSubstanceMood | x_DocumentSubstanceMood | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-xDocumentActMood | x_DocumentActMood | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-xDocumentEncounterMood | x_DocumentEncounterMood | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-xActMoodDocumentObservation | x_ActMoodDocumentObservation | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-xActRelationshipExternalReference | x_ActRelationshipExternalReference | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-xActRelationshipEntry | x_ActRelationshipEntry | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-xActRelationshipEntryRelationship | x_ActRelationshipEntryRelationship | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-xActRelationshipDocument | x_ActRelationshipDocument | active | 2014-03 | uv | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.11610 | x_ActRelationshipDocument | active | 2024-06 | us | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.16926 | HL7 BasicConfidentialityKind | active | 2024-06 | us | tho | ||
| hl7.terminology | R5 | v3-xEncounterPerformerParticipation | x_EncounterPerformerParticipation | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | cited-artifact-abstract-type | Cited Artifact Abstract Type | trial-use | 1 | cds | 2025-01 | uv | tho |
| hl7.terminology | R5 | title-type | Title Type | trial-use | 1 | cds | 2025-01 | uv | tho |
| hl7.terminology | R5 | v3-ActClassContainer | ActClassContainer | active | 2014-03 | uv | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1029.67 | Other Health Care Facility | active | 2025-05 | us | sct | ||
| hl7.fhir.us.pacio-pfe | R4 | pfe-survey-category-vs | Personal Functioning and Engagement Survey Value Set | trial-use | 3 | pc | 2025-07 | us | tho |
| hl7.terminology | R5 | v3-ActRelationshipHasSupport | ActRelationshipHasSupport | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ParticipationSubset | ParticipationSubset | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ActRelationshipSubset | ActRelationshipSubset | active | 2014-03 | uv | tho | ||
| hl7.fhir.us.icsr-ae-reporting | R4 | ICSRAESeriousness | ICSR Top-Level Seriousness | draft | 2023-08 | us | tho | ||
| hl7.terminology | R5 | v3-xInformationRecipient | x_InformationRecipient | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-xDocumentEntrySubject | x_DocumentEntrySubject | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-xInformationRecipientRole | x_InformationRecipientRole | active | 2014-03 | uv | tho | ||
| signal.core.r4 | R4 | data-absent-reason | DataAbsentReason | normative | 5 | fhir | 2019-10 | us | tho |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1240.4 | Asked Declined Data Absent Reason | active | 2023-06 | us | tho | ||
| hl7.terminology | R5 | v3-ActRelationshipTransformation | ActRelationshipTransformation | active | 2014-03 | uv | tho | ||
| hl7.fhir.uv.extensions | R5 | postal-address-use | PostalAddressUse | trial-use | 3 | fhir | 2023-01 | uv | tho |
| signal.core.r4 | R4 | questionnaire-dacods-admission-route-of-administration | Questionnaire DACODS Admission Route Of Administration | draft | 1 | pa | us | ||
| signal.core.r4 | R4 | questionnaire-dacods-discharge-route-of-administration | Questionnaire DACODS Discharge Route Of Administration | draft | 1 | pa | us | ||
| hl7.terminology | R5 | v2-0971 | hl7VS-onlineVerificationResultErrorCodes | active | 2019-12 | uv | tho | ||
| fhir.virtually.healthcare | R4 | VHConditionCode | VH Condition Code | draft | 2025-08 | us | sct | ||
| fhir.virtually.healthcare | R4 | VHImmunisationCode | VH Immunisation Code | draft | 2025-08 | us | sct | ||
| fhir.virtually.healthcare | R4 | VHMedicationCode | VH Medication Code | draft | 2025-08 | us | sct | ||
| fhir.virtually.healthcare | R4 | VHObservationCode | VH Observation Code | draft | 2025-08 | us | sct | ||
| fhir.virtually.healthcare | R4 | VHObservationValueCode | VH Observation Value Code | draft | 2025-08 | us | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.9 | ER Test for Orserdu | active | 2023-08 | us | ncit | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.185 | Spinal Surgery | active | 2024-06 | us | cms | ||
| hl7.fhir.it.terminology | R4 | vs-anagrafi-regionali | VS-Anagrafi Regionali | active | 2025-06 | it | ietf | ||
| hl7.fhir.be.terminology | R4 | be-vs-vaccination-bodysite | BeVSVaccinationBodySite | draft | 1 | 2025-03 | be | sct | |
| hl7.fhir.be.terminology | R4 | be-vs-vaccination-product | BeVSVaccinationProduct | draft | 1 | 2025-03 | be | ||
| fhir.giis | R4 | VaccinationSiteVS | Vaccination body site | draft | 2025-07 | us | internal | ||
| hl7.fhir.be.terminology | R4 | be-vs-vaccination-reason-code | BeVSVaccinationReasonCode | draft | 1 | 2025-03 | be | sct | |
| fhir.giis | R4 | VaccinationReasonVS | Vaccination reason | draft | 2025-07 | us | internal | ||
| hl7.fhir.be.terminology | R4 | be-vs-vaccination-confirmation-status | BeVSVaccinationConfirmationStatus | draft | 1 | 2025-03 | be | ||
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-vaccination-confirmation-status | Vaccination status Value Set | active | 2021-01 | internal | |||
| hl7.fhir.be.terminology | R4 | be-vs-vaccination-status-reason | BeVSVaccinationStatusReason | draft | 1 | 2025-03 | be | tho | |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-vaccination-status-reason | Vaccination status reason Value Set | active | 2021-01 | internal tho | |||
| hl7.fhir.be.terminology | R4 | be-vs-vaccination-administration-route | BeVSVaccineAdministrationRoute | draft | 1 | 2025-03 | be | tho | |
| ehealthplatform.be.r4.federalprofiles | R4 | be-vs-vaccination-administration-route | Vaccine Administration Route | active | 2021-01 | internal tho | |||
| hl7.fhir.be.terminology | R4 | be-vs-vaccine-code | BeVSVaccineCode | active | 1 | 2025-03 | be | sct | |
| hl7.fhir.be.terminology | R4 | be-vs-vaccine-target-disease | BeVSVaccineTargetDisease | draft | 1 | 2025-03 | be | ||
| fhir.giis | R4 | VaccineVS | Vaccine codes | draft | 2025-07 | us | internal | ||
| hl7.terminology | R5 | v3-VaginalRoute | VaginalRoute | active | 2014-03 | uv | tho | ||
| hl7.fhir.us.registry-protocols | R4 | NCDRErrorsVS | NCDRErrorsVS | active | cic | 2023-11 | us | fhir | |
| hl7.fhir.cl.minsal.nid | R4 | VSValoracionDesempeno | Valoracion Desempeño | active | 2023-01 | cl | internal | ||
| hl7.fhir.cl.minsal.eis | R4 | VSSituacionDiscapacidadNivel | Valoración de Desempeño en Comunidad (IVADEC-CIF) | active | 2022-01 | cl | internal | ||
| hl7.fhir.cl.minsal.eis | R4 | VSSituacionDiscapacidadOrigen | Valoración de Desempeño en Comunidad (IVADEC-CIF) | active | 2022-01 | cl | internal | ||
| hl7.fhir.cl.minsal.r2bo | R4 | r2bo-medida-margen-quirurgico-VS | Set de Valores de la Medida de Margen Quirúrgico | informative | oo | 2025-08 | cl | ucum | |
| HIE2.packages | R4 | results-pathology-observations-uv-ips | Results Pathology Observation - IPS | active | 2022-01 | uv | loinc | ||
| hl7.fhir.uv.ips | R4 | results-radiology-observations-uv-ips | Results Radiology Observation - IPS | trial-use | 2 | pc | 2025-08 | uv | loinc |
| hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.40--20240802104807 | IPS Results Radiology Observation | draft | 2024-08 | uv | loinc | ||
| HIE2.packages | R4 | results-laboratory-observations-uv-ips | Results Laboratory Observation - IPS | active | 2022-01 | uv | loinc | ||
| hl7.fhir.uv.ips | R4 | results-laboratory-pathology-observations-uv-ips | Results Laboratory/Pathology Observation - IPS | trial-use | 2 | pc | 2025-08 | uv | loinc |
| us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.3.1489 | ACE Inhibitor or ARB or ARNI Ingredient | active | 2023-02 | us | vsac | ||
| hl7.fhir.cz.lab-order | R4 | cz-typeClinicalEvent-vs | Valueset of types Clinical event (CZ) | trial-use | 2 | 2024-01 | cz | internal | |
| hl7.fhir.it.terminology | R4 | statoEsenzione | Stato Esenzione | active | 2025-06 | it | tho | ||
| hl7.fhir.us.davinci-pct | R4 | PCTAdjudicationCategoryVS | PCT GFE Item Adjudication Value Set | trial-use | fm | 2025-08 | us | fhir tho | |
| hl7.fhir.be.terminology | R4 | be-vs-populationscreening-next-invitation-type | Population Screening Next Invitation Type Value Set | active | 1 | 2024-06 | be | ||
| hl7.fhir.uv.cow | R4 | message-header-event | Clinical Orders Workflow - Message Header Event Codes | trial-use | 1 | oo | 2025-05 | uv | fhir |
| hl7.fhir.uv.radiation-dose-summary | R4 | component-radiation-dose-summary-vs | Radiation Dose Summary component type | trial-use | 2 | ii | 2025-05 | uv | sct dcm |
| ch.fhir.ig.ch-epl | R5 | ch-authorisation-type | CH - Authorisation Type | active | 2025-05 | ch | internal | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-appointmentstatus | Appointment Status | active | 2025-05 | ch | fhir | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-consentstatus | Consent Status | active | 2025-05 | ch | internal sct | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-coverageidentifiertype | Coverage Identifier Type | active | 2025-05 | ch | internal | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-desiredaccommodation | Desired Accomodation | active | 2025-05 | ch | |||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-encounterclass | Encounter Class | active | 2025-05 | ch | tho | ||
| ch.fhir.ig.ch-epr-fhir | R4 | PpqmConsentIdentifierType | CH PPQm Consent Identifier Type | active | 2025-05 | ch | internal | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.10.20.22.5.305 | Microbiology and Antimicrobial Susceptibility Tests | active | 2024-06 | us | loinc | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-legalrelation | Legal Relation | active | 2025-05 | ch | sct | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-limitationstatus | CH EPL - Limitation Status | active | 2025-05 | ch | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-listing-status | CH EPL - Listing Status | active | 2025-05 | ch | internal | ||
| hl7.fhir.us.directory-query | R4 | OrganizationAffiliationRoleVS | OrganizationAffiliation Roles | active | 2022-12 | us | fhir | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | OrganizationAffiliationRoleVS | OrganizationAffiliation Roles | trial-use | fm | 2025-02 | us | fhir | |
| hl7.fhir.us.ndh | R4 | OrganizationAffiliationRoleVS | OrganizationAffiliation Roles | trial-use | pa | 2025-07 | us | fhir tho | |
| hl7.fhir.us.directory-attestation | R4 | OrganizationAffiliationRoleVS | OrganizationAffiliation Roles | active | 2022-12 | us | fhir | ||
| ch.fhir.ig.ch-epl | R5 | ch-other-characteristics-type | CH - Other Characteristics Type | active | 2025-05 | ch | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-other-characteristics-packaged-item | CH EPL - Other Characteristics Packaged Item | active | 2025-05 | ch | internal | ||
| ch.fhir.ig.ch-epr-ppqm | R4 | PpqmConsentIdentifierType | PPQm Consent Identifier Type | active | 2023-12 | ch | internal | ||
| ch.fhir.ig.ch-orf | R4 | ch-orf-vs-personalrelation | Personal Relation | active | 2025-05 | ch | sct | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-pricetype | CH EPL - Price Type | active | 2025-05 | ch | internal | ||
| hl7.fhir.us.qicore | R4 | qicore-present-on-admission | QICore Present On Admission Codes | trial-use | 4 | cqi | 2021-05 | us | cms |
| fhir.nigeriaImmunization | R4 | register-client-valueset | IMMZ.C Value Set for Registering Clients | active | 2025-08 | us | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-reimbursement-status | CH EPL - Reimbursement Status | active | 2025-05 | ch | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-type-of-price-change | CH EPL - Type of Price Change | active | 2025-05 | ch | internal | ||
| hl7.fhir.uv.genomics-reporting | R4 | tbd-codes-vs | To Be Determined Value Set | informative | cg | 2025-06 | uv | fhir | |
| hl7.fhir.uv.genomics-reporting | R4 | condition-inheritance-mode-vs | Condition Inheritance Patterns | trial-use | 2 | cg | 2025-06 | uv | gene |
| hl7.fhir.be.terminology | R4 | be-vs-coded-annotation-types | Coded Annotation Types | active | 1 | 2022-09 | be | ||
| hl7.fhir.uv.genomics-reporting | R4 | coded-annotation-types-vs | Coded Annotation Types | trial-use | 2 | cg | 2025-06 | uv | fhir |
| hl7.fhir.uv.genomics-reporting | R4 | sequence-phase-relationship-vs | Sequence Phase Relationships | trial-use | 2 | cg | 2025-06 | uv | tho |
| hl7.fhir.uv.genomics-reporting | R4 | molecular-biomarker-code-vs | Molecular Biomarker Codes | trial-use | 2 | cg | 2025-06 | uv | ncit loinc |
| hl7.fhir.uv.genomics-reporting | R4 | genetic-therapeutic-implications-vs | Genetic Therapeutic Implications | trial-use | 2 | cg | 2025-06 | uv | sct loinc |
| ch.fhir.ig.ch-epl | R5 | ch-SMC-additional-monitoring-indicator | CH SMC- Additional Monitoring Indicator | active | 2025-05 | ch | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-authorisation-category | CH SMC - Authorisation Category | active | 2025-05 | ch | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-authorisation-status | CH SMC - Authorisation Status | active | 2025-05 | ch | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-authorised-pharmaceutical-dose-form | CH SMC - Authorised Pharmaceutical Dose Form | active | 2025-05 | ch | internal | ||
| ch.fhir.ig.ch-epl | R5 | edqm-combination-packaging | EDQM - Combination Packaging | active | 2025-05 | ch | |||
| ch.fhir.ig.ch-epl | R5 | edqm-combined-pharmaceutical-dose-form | EDQM - Combined Pharmaceutical Dose Form | active | 2025-05 | ch | |||
| ch.fhir.ig.ch-epl | R5 | edqm-combined-term | EDQM - Combined Term | active | 2025-05 | ch | |||
| ch.fhir.ig.ch-epl | R5 | ema-domain | EMA - Domain | active | 2025-05 | ch | |||
| ch.fhir.ig.ch-epl | R5 | ch-epl-foph-gamme | CH EPL - Gamme | active | 2025-05 | ch | internal | ||
| ch.fhir.ig.ch-epl | R5 | ch-SMC-ingredient-role | CH SMC - Ingredient Role | active | 2025-05 | ch | internal |
FHIR